Moebius Syndrome Research at the National Institutes of Health
Ethylin Jabs, MD. Professor and Vice Chair of Genetic and Genomic Sciences, Professor of Pediatrics and Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai
Elizabeth C. Engle MD. Professor of Neurology and Ophthalmology, Boston Children’s Hospital & Harvard Medical School. Investigator, Howard Hughes Medical Institute.
Eirini Manoli MD, PhD. Staff Clinician, National Human Genome Research Institute, National Institutes of Health
To the Moebius Syndrome Foundation:
We are pleased to announce a collaborative effort amongst a team of researchers at Mount Sinai School of Medicine, Boston Children’s Hospital and the National Institutes of Health, that aims to characterize the clinical phenotype of children and adults with Moebius syndrome and associated congenital facial weakness disorders and use genetic studies to identify disease-causing genes.
Participants are eligible if between 2 and 80 years old and have an established diagnosis of Moebius syndrome or other disorders associated with congenital facial weakness, based on clinical history and findings. Investigators will apply rigorous selection criteria to choose about 30 families per year for an evaluation at the National Institutes of Health Clinical Center in Bethesda, Maryland. During a three- to five-day outpatient stay, participants will undergo a physical examination, meet many specialties, including geneticists, ophthalmologists, neurologists and rehabilitation medicine doctors, and have a blood sample drawn to extract DNA (genetic material).
The NIH research team will use advanced technologies for brain imaging and to test the patient’s DNA for possible genetic causes of these disorders. It is important to also obtain DNA from both the patient’s parents, but the parents would not necessarily have to travel to NIH in person.
Combining our unique expertise and resources will maximize our ability to make new discoveries that will help understand what causes Moebius syndrome and provide more accurate diagnosis and genetic counseling for individuals with facial weakness and their families.
For more information regarding the study, please respond with your contact information to the phone numbers/email address below:
Carol Van Ryzin 301-827-1071
Eirini Manoli 301-402-2543
Update May 2015:
Updates on Moebius Syndrome and other Congenital Facial Weakness Disorders
Greetings from the Study on Moebius Syndrome and other Congenital Facial Weakness disorders.
Thank you to all of you who have participated or contacted us with regards to this wonderful collaborative effort between Mount Sinai Health Systems, Boston Children’s Hospital and the National Institutes of Health. We have some brief updates with regards to the study.
- 17 participants affected with Moebius Syndrome or other Congenital Weakness disorders (and their family members) have been evaluated at the National Institutes of Health (NIH) clinical Center in Bethesda, Maryland
- 15 additional participants and their family members are scheduled to be seen this Spring/Summer
- A secure database system has been set up to share data that has been collected at other sites. Close to 300 people have been entered into the database system.
- Monthly teleconferences have been held amongst the collaborators to discuss the study’s progress and plans going forward
- Our 2nd in-person meeting will be held at the NIH this Summer
It has been quite a successful year of collaboration and we will continue to maximize our efforts to make new discoveries and advances toward a better understanding of Moebius syndrome and other congenital facial weakness disorders.
If you would like to have more information about the study please contact Carol Van Ryzin, RN, CPNP by phone at 301-827-1071 or by e-mail at email@example.com.